Chamber and committees

The Scottish Government and Public Health Scotland do not currently hold data on the number of people eligible for a Covid-19 vaccine who are unable to receive one due to needle phobia.

As every individual case is different, all those who suffer from needle phobia should initially seek support from their GP, clinician or local health board so that adjustments can be made to accommodate their specific needs. Their local medical team will be more aware of their specific requirements. The staff delivering the vaccines are skilled and experienced, and will be used to dealing with more nervous patients, some of whom have phobias.

Phobias are not covered under the current version of the vaccination certification policy, and are therefore not considered a valid exemption.

The Scottish Government is supporting vital research into the immune response to COVID-19 after infection and vaccination, which is being undertaken by the SIREN (Sars-CoV-2 Immunity & Reinfection Evaluation) research study. The primary aim of the study is to determine whether the presence of antibodies to SARS-CoV-2 (anti-SARS-CoV-2) is associated with a reduction in the subsequent risk of re-infection over short term periods (reviewed monthly), the next year and in the longer-term. It will help us understand whether a previous infection of SARS-CoV-2 will offer an individual any protection against future infection of the same virus.

The Scottish Government is also participating in the recently launched Post Positive PCR Antibody Testing Initiative (PPPATI), which is using antibody testing to further our understanding of vaccine effectiveness and the immune response to COVID-19.

It is not. The change to routine cervical screening intervals from three years to five years is due to the implementation of a test for high risk human papillomavirus (HPV) as the primary screening test in March 2020. The new test is more effective at identifying those at risk of developing cervical cancer, meaning women who don’t have HPV will be invited for a cervical screening test every five years instead of every three.

The performance and attainment data published by The Times was obtained from the Scottish Government and is publicly available via the School Information Dashboard Profile | Tableau Public . The Scottish Government does not produce school league tables and never will. The guidance published alongside the data makes it clear that statistical data alone is not a measure of how well a school is doing. All schools are unique. To properly understand how well a school is doing it is important to look at a range of different data sources, together with information about the individual school.

A wide range of school performance and attainment data is collected and analysed by the Scottish Government to inform the National Improvement Framework and Improvement Plan for education. The information gathered identifies where further improvements can be made which will, in turn, contribute to delivering our priorities to deliver equity and excellence in Scottish education.

The following table shows the number of samples collected within the cervical screening programme from 1 January 2019 to 26 August 2021. As part of the response to the COVID-19 pandemic, the cervical screening programme was paused between 30 March 2020 and 29 June 2020. The table below shows that a small number of samples were collected during this time; this is because colposcopy and gynaecology continued taking samples for clinical management, and some GP practices continued screening for those on non-routine recall.

Screening resumed on 29 June 2020 in a phased, careful and prioritised way, as part of the remobilisation of the NHS in Scotland. Anyone who was invited for cervical screening before the pause in March and had yet to make an appointment or had it cancelled was able to make an appointment from 29 June 2020. Non-routine cervical screening appointments resumed in mid-July and routine screening appointments from September 2020.

It is important to note that the data below is management information and has not been subject to the necessary quality checks carried out for an official publication.

I refer the member to the answer to question S6W-02045 on 25 August 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The Scottish Government expects everyone to be treated with consideration, dignity and respect when accessing and using NHS services. NHS staff will make every effort to ensure that the privacy and dignity of all patients are maintained in Scottish hospitals.

All patients should routinely be cared for in wards or bays which are for single sex occupancy. The Scottish Government provided guidelines and recommendations on the elimination of mixed sex accommodation in 1999 and 2000. Further guidance and direction regarding the provision of clinically appropriate single room accommodation in all planned new buildings and major refurbishments was provided in 2008 and 2010.

The Scottish Government is actively working with partners and people with lived experience to develop Scotland’s approach to self-harm; this is a commitment in the Mental Health Transition and Recovery plan.

In developing our approach we are considering how best to deliver our objective to ensure compassionate, trauma informed responses to people in distress who self-harm, whilst also reducing stigma.

Our initial work on self-harm included commissioning Samaritans Scotland to undertake research, which resulted in the publication of ‘Hidden too long: uncovering self-harm in Scotland’ ( https://media.samaritans.org/documents/HiddenTooLong_uncoveringself-harminScotland.pdf ). In line with that research, we have continued to engage with partners and people with lived experience to better understand the prevalence and nature of self-harm. Through the Mental Health Recovery and Renewal fund, work is being commissioned to pilot self-harm support services, develop a website to support people who self-harm and design a programme of learning for professionals. Crucially, this research, engagement and evaluation from pilots will inform our policy approach.

Our focus has been, and remains, on keeping our school communities safe including minimising the risk of any long-term impact of the pandemic. The First Minister confirmed in her update to Parliament on 14 September, that we are retaining the current suite of mitigations in schools for the time being. This decision follows the latest recommendations of the advisory sub-group on education and children’s issues, and was taken after very careful consideration. The measures in place in schools and across wider society are crucial in reducing infection but we will continue to keep the requirements under very close review.

The vast majority of medicinal cannabis products remain unlicensed with a limited, or non-existent, peer-reviewed clinical evidence base. Under the current rules, only specialist doctors on the General Medical Council’s specialist register can prescribe cannabis-based products where there is clear published evidence of benefit. We are encouraging companies to participate in clinical trials so that these products can be tested for quality, safety and efficacy and brought forward for approval through the medicine regulatory and health technology assessments processes. This will enable these products to be readily available through the NHS – provided they met the clinical safety requirements for licencing and the clinical and cost effectiveness approval for routine use in the NHS.